“Science and Technology Innovation Board Daily”, December 1 — The main contents of today's Science and Technology Innovation Board evening report include: Shanghai: 3-5 parks in the Zhangjiang High-tech Zone will reach a trillion-level industrial scale by 2025; Innotek plans to subscribe for private equity shares of 20 million yuan; and Junshi Biotech: The triplizumab marketing license application has been accepted by the Australian Drug Administration.

[Focus on hot topics]

Newsletters:

Shanghai: By 2025, 3-5 parks in the Zhangjiang High-tech Zone will reach a trillion-level industrial scale

Shanghai issued “Certain Opinions on Promoting Reform, Innovation, Development and Construction of World-leading Science and Technology Parks in the Zhangjiang High-tech Zone” to cultivate a number of world-class enterprises with benchmark exemplary significance, and to achieve characteristic development of leading industries in key parks. By 2025, there will be more than 100 “unicorn” and “invisible champion” enterprises, and the three leading industries will account for more than 85% of the total scale of the city. By 2025, 3-5 parks will reach a trillion-level industrial scale, the talent scale of the three leading industries will reach 800,000, the number of high-quality incubators will reach 20, and an average of 200 new technology enterprises will be added every day.

The “Regulations on Promoting the Development of Intelligent Vehicle Networks in Suzhou” officially came into effect

The “Regulations on Promoting the Development of Smart Vehicle Networks in Suzhou” are officially implemented. The “Regulations” provide legal guarantees for the first testing of smart vehicle networks in Suzhou, orderly testing of road networks, and the agglomeration and development of related industries. The main contents of the “Decision” include clarifying high-quality development ideas, guiding industrial innovation and collaborative development, increasing financial support, promoting the construction of Internet of Vehicles infrastructure, exploring and expanding application fields, and strengthening network and data security protection. According to the “Suzhou Intelligent Vehicle Internet Industry Innovation Cluster Action Plan (2023-2025)”, by 2025, Suzhou will strive to achieve a scale of 100 billion yuan in the intelligent vehicle network industry, gathering more than 1,000 industry-related enterprises.

Depth:

Gaojing Solar, which raised more than 4 billion yuan in four years and valued at 20 billion yuan, once again sprinted into the IPO

Ronaldo was claimed 1 billion US dollars, O'Neill, Curry, and many other stars were involved in the biggest cryptocurrency claim case staged in the US

The world's only adjuvant bladder cancer developer drug accepted by NDA Yahong Pharmaceutical: although it is niche, clinical demand is high

Medicare: RF wafer packaging production capacity reaches 4000 K/month, nano-imprint products are expected to be shipped in batches in Q1 next year | Direct impact on the performance meeting

[Science and Technology Innovation Board Announcement]

Sanwei Xin'an: Plans to repurchase shares for 40 million yuan to 80 million yuan

Sanwei Xin'an announced that it plans to repurchase shares at 40 million yuan to 80 million yuan, with a repurchase price of no more than 73.33 yuan/share. The repurchased shares are intended for employee stock ownership plans or equity incentives. The company announced on the same day that it plans to set up a wholly-owned subsidiary in Hong Kong for 5 million US dollars.

Huahong Company: Subsidiaries sign technology development agreements

Huahong announced that Shanghai Huahong Hongli Semiconductor Manufacturing Co., Ltd., a wholly-owned subsidiary, and Shanghai Huali Microelectronics Co., Ltd. signed a “Technology Development Agreement”. The transaction amount is between 110 million yuan and 180 million yuan.

Innotek: Plans to subscribe for private equity shares for 20 million yuan

Innotek announced that Jingda Guangyuan, a wholly-owned subsidiary of the company, plans to sign a “partnership agreement” with Tianjin Hongchuang and other partners as a limited partner to jointly fund the establishment of the private equity fund Hongchuang Haihe. The company plans to pledge an investment of RMB 20.0 million from its own funds, accounting for 11.80% of the total amount pledged by the fund. On the same day, it was announced that Jingda Guangyuan, a wholly-owned subsidiary of the company, plans to sign a “partnership agreement” with Beijing **** Venture Consulting Partnership (Limited Partnership) and other partners as a limited partner to pledge the additional partnership share of the private equity fund Yuansheng Beijing Angel Phase II. Yuansheng Beijing Angel Phase II will focus on the medical and health sector in China and invest in unlisted companies belonging to these fields. The company plans to pledge an investment of RMB 500,000 from its own capital. The proposed investment ratio is 4.42% of the total amount pledged by the fund, based on the actual share after signing the “Partnership Agreement”.

Junshi Biotech: Treprilizumab marketing license application accepted by the Australian Medicines Agency

Junshi Biotech announced that Junshi Biotech voluntarily disclosed that the marketing license application for treprilizumab was accepted by the Australian Medicines Agency.

Yahuilon: Anti-BP180 antibody test kit obtained medical device registration certificate

Yahuilong announced that the company recently received a medical device registration certificate issued by the Guangdong Drug Administration. The product name is an anti-BP180 antibody test kit (chemiluminescence method), which is used to qualitatively test anti-BP180IgG antibodies in human serum in vitro. Clinically, it is mainly used for auxiliary diagnosis of bullous pemphigoid.

Artes: 2,626,500 restricted shares will be listed and distributed from December 11

Artes announced that the sale restrictions have been lifted and the number of shares applied for listing for circulation is 2,626,500 shares. Currently, the lockdown period is about to expire, and will be listed for circulation on December 11, 2023.

[Venture capital weather vane]

Anqiwei Microelectronics receives strategic investment from China Mobile and others

Anqiwei Microelectronics recently received a strategic investment from a fund owned by China Mobile. Anqiwei Microelectronics is a silicon process microwave integrated circuit developer and manufacturer, focusing on developing customized products such as high-performance analog, radio frequency, microwave and millimeter wave integrated circuits, modules, and broadband transceivers based on germanium silicon SiGe, insulated silicon SOI, and silicon CMOS processes.

Wang Huiwen takes a stake in Yuan Jinhui's Silicon Motion Technology

According to Tianyan survey, recently, Beijing Silicon Technology Co., Ltd. underwent industrial and commercial changes, adding Wang Huiwen as a shareholder. At the same time, the registered capital increased from 1 million yuan to about 1,0526 million yuan. The company was founded in August this year. The legal representative, executive director, and manager is Yuan Jinhui, founder of OneFlow. The company's business scope includes software development, technology import and export, electronic product sales, artificial intelligence application software development, artificial intelligence general application systems, and artificial intelligence industry application system integration services. According to public information, after Wang Huiwen was on sick leave, OneFlow, the core team acquired by Lightyear away, announced that it would start a new business. Yuan Jinhui said that the new venture project plans to solve the problem of large model reasoning costs. According to Tianyan Research, at present, Wang Huiwen is still a director of Beijing First-Class Technology Co., Ltd., a OneFlow affiliate.

Lu Xin New Materials completed Series B financing of over 120 million yuan

Recently, Lu Xin Xincai completed Series B financing of more than 120 million yuan. This round of financing was jointly invested by Yuanhe Puhua, Huashan Capital, Borui Capital, and individual investors, and Wanchuang Investment Bank acted as the chief financial adviser. Lu Xin Xincai is a developer of metal powder production equipment. The company's main products include VIGA vacuum induction gas atomization milling furnace, 3D printing powder collection equipment, powder development centers, and powder testing equipment. At the same time, the company's business also involves technical consulting on metal powder production.

Zhongke Huiyuan completed hundreds of millions of yuan in round C+ financing

Zhongkehui, a provider of integrated solutions for machine vision technology, has recently completed the C+ round of financing of hundreds of millions of yuan. This round of financing includes investors such as the Beijing China Mobile Digital New Economy Industry Fund, the Chinese Academy of Sciences Capital, Haitong CCTV Finance and Media Industry Investment Fund, Shenwan Innovation Investment, Qi Xin Capital, and the Luoyang Intellectual Property Operation and Development Fund. This round of funding will mainly be used for research and development in new directions, expansion in new fields, and expansion of domestic and foreign markets.

Aeroscape Innovation completed the B+ round of financing of over 100 million yuan

Recently, Hangjing Innovation completed a B+ round of financing of over 100 million yuan. This round of financing was led by Yizhuang SDIC and Yuanhang Capital, followed by SDIC Taikang and Zhongguancun Venture Capital. Aeroscape Innovation is a developer of heavy-duty unmanned helicopters. It is mainly engaged in the development and application of heavy-duty unmanned helicopter products.